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Abstract:  Private  health  insurance    serves  three  distinct  functions  in  western 
European health systems. The first is as an alternative for mandatory (statutory) social 
health insurance arrangements. The second function is to supplement statutory insurance, 
providing coverage for services not covered by social insurance. A third function of private 
health  insurance  is  to  provide  what  can  be  termed  complementary  coverage,  in  which 
insured persons purchase additional private insurance even while they have to participate 
in existing social schemes. 
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1. INTRODUCTION  
There is a major contradiction between the goal of improving health and the reality 
in most European health systems. If this is to change what must happen? Perhaps the most 
important thing, that is often overlooked, is that health policy makers must take account of 
the changing nature of disease and the responses to it. 
The systems introduced in this region since 1990 imply that health care involves 
only brief, clearly defined interactions between individual patients and providers. Yet a 
combination  of  aging    populations  and  new  therapeutic  opportunities  mean  that  an 
increasingly  large  volume  of  health  care  will  be  for  chronic  disorders,  requiring  co-
ordinated interventions by different professionals and specialists over a prolonged period 
of time. But many of the detailed reforms of health services, such as the introduction of 
Diagnosis Related Groups, go in the opposite direction, seeking to package health care into 
isolated, homogenous interventions. 
This paper sets out a series of functions that are required if the impact of health 
care on health is to be optimised. Unfortunately, many of the reforms introduced so far 
have done little to address previous and present issues. Of course the situation in western 
Europe, and mainly the one in Eastern Europe, is far from ideal, with many health care 
systems failing to address health needs equitably or to optimise use of resources.  
The question remains wheather Romania is able to assess the benefits, learn from 
mistakes and find a way to become a player on this market, thus improving healthcare 
thoroughout the nation. 
2. THE EUROPEAN HEALTH INSURANCE MARKET 
Private  or  voluntary  health  insurance  does  not  play  a  significant role  in  many 
health systems in the European Union (EU), either in terms of funding or as a means of 
gaining access to health care. In most EU member states it accounts for less than 5% of   2
total expenditure on health and covers a relatively small proportion of the population. The 
exceptions  to  this  trend  are  France,  Germany  and  the  Netherlands.  Voluntary  health 
insurance fulfils different roles in different contexts. In the EU context it can be classified 
according  to  whether  its  role,  in  relation  to  statutory  health  insurance,  is  substitutive, 
complementary or supplementary. Substitutive voluntary health insurance provides cover 
that would otherwise be available from the state. 
Complementary voluntary health insurance provides cover for services excluded or 
not fully covered by the state, particularly cover for statutory user charges, as in Croatia, 
Denmark, France and Slovenia. Supplementary voluntary health insurance provides cover 
for  faster access  and increased  consumer  choice and  is  available  in  most  EU  member 
states. Voluntary health insurance may increase access to health care for those who are 
able to purchase an adequate and affordable level of private cover. At the same time it is 
likely to present barriers to access, particularly for older people, people in poor health and 
people with low incomes.  
The greater the role of voluntary health insurance in providing access to effective 
health  services  that  are  a  substitute  for  or  complement  to  those  provided  by  the 
government, the larger the impact it will have on access to health care. Access to health 
care  within  voluntary  health  insurance  markets  is  heavily  dependent  on the regulatory 
framework in place and the way in which insurers operate. It may be affected by how 
premiums are rated, whether they are combined with cost sharing, the nature of policy 
conditions, the existence of tax subsidies to encourage take up or cross-subsidies to the 
statutory health care system and the characteristics of those who purchase it. It may also be 
affected by whether or not benefits are provided in cash rather than in kind, the way in 
which  providers  are  paid  and  the  extent  to  which  policies  are  purchased  by  groups  – 
usually employers – rather than individuals. Due to information failures in private health 
insurance markets, insurers need to find ways of assessing an individual’s risk of ill health 
in order to price premiums on an actuarially fair basis.  
However,  accurate  risk  assessment  is  technically  difficult  and  expensive  to 
administer. Consequently, insurers have strong incentives to select risks – that is, to attract 
people with a mower than average risk of ill health and deter those with a higher than 
average risk. Some regulatory measures will increase insurers’ incentives to select risks – 
for example, requiring insurers to offer community-rated premiums – while others, such as 
risk adjustment mechanisms, aim to reduce these incentives. However, even if explicit risk 
selection is prohibited by requiring insurers to offer open enrolment and to cover pre-
existing conditions, insurers may engage in covert forms of risk selection.  
Insurers in European private health insurance markets are generally subject to a 
low  level  of  regulation.  In  most  non-substitutive  voluntary  health  insurance  markets 
regulation is exclusively concerned with ensuring that insurers remain solvent rather than 
issues of consumer protection. Ireland is the only country in which insurers are required to 
offer open enrolment, community-rated premiums and lifetime cover and are subject to a 
risk equalization scheme. Elsewhere insurers are permitted to reject applications for cover, 
exclude or charge higher premiums for pre-existing conditions, rate premiums according to 
risk, provide nonstandardized benefit packages and offer annual contracts. Benefits are 
usually provided in cash – that is, insurers reimburse individuals for their health care costs. 
In loosely regulated voluntary health insurance markets older people, people in poor health 
and people with low incomes are likely to find it difficult to obtain affordable coverage. 
People in poor health may not be able to purchase any cover.  
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 Governments intervene more heavily in markets for substitutive voluntary health 
insurance in Germany and the Netherlands where, as a result of risk selection by insurers, 
older people and people with chronic illnesses have not been able to purchase sufficient 
cover. Risk selection by insurers has also contributed, to some extent, to the financial 
instability  of  the  statutory  health  insurance  scheme,  which  covers  a  disproportionate 
amount of older people in both countries. 
Changes  in  regulation  to  prevent  further  destabilization  of  statutory  health 
insurance in the Netherlands in 1986 and in Germany in 1994 and 2000 mean that some 
people with relatively low incomes no longer have access to statutory coverage and must 
rely on substitutive voluntary health insurance. For this reason insurers in both countries 
are  required  to  provid  e  older  people  with  standardized  benefit  packages  –  providing 
similar  benefits  to  statutory  coverage  –  for  a  premium  regulated  by  the  government. 
Insurers  in  Germany  are  also  required  to  offer  lifetime  substitutive  voluntary  health 
insurance cover. In the  Netherlands younger people with substitutive voluntary health 
insurance are required to cross - subsidize the premiums of older people and all policy 
holders  must  make  an  annual  contribution  to  the  statutory  health  insurance  scheme. 
Complementary  voluntary  health  insurance  covering  cost  sharing  is  likely  to  present 
barriers to access for people with low incomes, particularly those with incomes just above 
the threshold for any exemptions from cost sharing that may exist. It is both inequitable 
and inefficient for governments to establish a price mechanism through cost sharing and 
then  negate  the  effect  of  price  for  those  who  can  afford  to  purchase  complementary 
voluntary health insurance. 
Complementary voluntary health insurance is most prevalent in France, where it 
covered  85%  of  the  population  in  1998.  Research  shows  that  the  likelihood  of  being 
covered by complementary voluntary health insurance is highly dependent on social class, 
income levels, employment status, level of employment and age. Furthermore, the quality 
of coverage provided by complementary voluntary health insurance increases significantly 
with income. In order to address the inequalities in access to health care arising from 
unequal  access  to  complementary  voluntary  health  insurance,  the  French  government 
introduced a law on universal health coverage in 2000, extending free complementary 
voluntary health insurance coverage to people earning less than €550 per month. 
Supplementary private health insurance often provides faster access to health care 
by enabling people to bypass waiting lists in the public sector. It can also provide access to 
a wider range of providers. However, if supplementary health insurance does not operate 
independently  of  the  statutory  health  system,  it  may  distort  the  allocation  of  public 
resources for health care, which may restrict access for those who are publicly insured. 
This  could  happen  if  boundaries  between  public  and  private  provision  are  not  clearly 
defined, particularly if capacity is limited, if providers are paid by both the public and the 
private  sector  and  if  voluntary  health  insurance  creates  incentives  for  health    care 
professionals  to  treat  public  and  private  patients  differently.  Governments  in  some 
countries, for example, Ireland, have found that the existence of private health insurance 
can  reduce  access  for  publicly  funded  patients  and  are  taking  steps  to  clarify  the 
boundaries between public and private provision of health care. 
Voluntary health insurance tends to incur higher management and administrative 
costs than statutory health insurance, partly because pool size is smaller, but mainly due to 
the extensive bureaucracy required to assess risk, set premiums, design benefit packages 
and  review,  pay  or  refuse  claims.  Insurers  also  incur  additional  expenses  through 
advertising,  marketing,  distribution,    reinsurance  and  the  need  to  generate  a  profit  or   4
surplus. Within the EU context, these additional costs cannot be justified on the grounds 
that  insurers  are  innovative  in  devising  mechanisms  to  contain  costs.  In  practice,  EU 
insurers are more likely to compete on the basis of risk selection than through competitive 
purchasing.  Most  attempts  to  contain  costs  operate  on  the  demand  side,  through  cost 
sharing. Transaction costs have not been lowered as a result of increased liberalization of 
voluntary  health  insurance  markets  in  the  EU  since  1994.  In  Ireland  higher  levels  of 
advertising  following    liberalization  have  actually  increased  transaction  costs.  Overall, 
private  health  insurance  requires  careful  regulation  to  ensure  access  to  health  care, 
guarantee consumer protection and stimulate efficiency gains. The existence of voluntary 
health insurance is likely to create barriers to access and may reduce equity and efficiency 
in the health system as a whole. Furthermore, unless there are clear boundaries between the 
public  and  the  private  sector,  voluntary  health  insurance  may  distort  the  allocation  of 
public resources for health care, to the detriment of those who are insured by statutory 
health insurance. 
3. THE NEED FOR REFORM IN THE ROMANIAN HEALTH SECTOR 
Romania’s health insurance market is stuttering into life, but is restricted by the 
financial crisis, a lack of comprehensive private medical providers and an absence of long-
term  Government  policy.  On  the  whole,  health  insurance  is  a  product  purchased  by 
companies  for  their  employees  as  an  extra  incentive  -  it  is  a  professional,  middle-
management  and  middle-class  product.  Rich  people  do  not  need  an  insurance  policy, 
because they can pay private medical providers cash up-front. But in 2009 companies 
looking to cut back on expenses made health insurance a casualty, thus the system has 
been blocked while many individuals could not afford to pay for comprehensive health 
insurance from their own pocket. 
Healthcare in Romania suffers from a massive budget shortfall. There are fewer 
than five million contributors and more than 20 million beneficiaries. There is a poor 
quality state service, which is plagued by bribes between patients and medical staff. Many 
have fought for health insurance to be fully deductible from all the social taxes. The hope 
is that a minority who take out health insurance for private care will lift the burden on the 
state system. Although this will mean less cash to the state, the capitalist argument is that 
the private system can use the money in a more efficient way. At present health coverage is 
only deductible from the profit tax of a company and few companies are making a profit. 
Overall  reform  is  needed  in  the  health  market.  Therapeutic  guidelines  are  not 
followed. Health costs are rising and the income from taxes is low. The state system is not 
well-managed and there is little competition.  
Private  health  insurance  is  yet  to  grow  in  Romania,  due  in  part  to  the 
Government’s delay in deciding its minimum package of free healthcare services. The 
sector is worth less than 0.5 per cent of the country’s total insurance market, a small figure 
of only ten million Euro.  
The  first  major  drawback,  is  the  Government’s  failure  to  define  a  minimum 
package of medical services covered by the state. At present Romania’s national health 
service is, on paper, free at the point of access. It is funded by five million of Romania’s 
wage-earners, who pay a national health insurance contribution to the National House of 
Health  Insurance  (CNAS).  There  are  moves  in  the  Ministry  of  Health,  however,  to 
calculate a minimum package of free services for citizens, with any additional services 
requiring a charge. However this would mean an ideological shift in the credo of universal  
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health  service  in  Romania,  especially  if  paid-for  services  included  operations  which 
blighted the poorest and most vulnerable members of Romanian society.  
Nevertheless such a definition would bring some clarity to a public system which 
is, at best, disorganised and, at worst, corrupt. It may help in decreasing the amount of 
informal payments or bribes which patients ‘unofficially’ pay doctors and medical staff for 
services, particularly in hospitals. It would also allow private insurance companies to know 
exactly which additional services they can provide.  
It has been argued that there is a reality gap between the funding base of the health 
service and the needs of the population. The current public healthcare package, on paper, 
covers all forms of sickness. This puts huge pressure on a sum of money collected from 
only five million taxpayers with an average monthly salary of around 400 Euro, on a 
system which caters for 22 million people.  
The government is reluctant to define this minimum package because it would 
have to inform its electorate that the money they contribute to the state for health insurance 
covers very few services. To make this assessment, the Ministry of Health must assess the 
precise cost for every medical service. This is also difficult to calculate because costs 
constantly shift in price.  
It is believed that a model that could work in Romania is the Netherlands model, if 
both employer and employee pay a percentage to a centralised National House of Health 
Insurance, from which a part is redirected to the private sector and the remainder to the 
basic package for every individual. This would be a similar scheme to Romania’s private 
pension market which, in 2006, became obligatory for people under 35 years of age.  
The  main  reason  Romania’s  private  health  insurance  market  is  behind  Poland, 
Germany and Austria is the slow reform in both medical infrastructure and allowing fiscal 
deductabilities or incentives to attract foreign investors. Investments needed in health are 
very large and an investor will put 10,000s Euro in a private hospital only if he has the 
certainty of a continuous flow of clients, in order to turn a profit.  
The second major problem in the private health insurance market is an insufficient 
number of medical providers which can offer sophisticated services at a certain quality 
level. Private health insurance products are dependent on the quality of their network of 
suppliers, a consistency of which is still lacking in Romania.  
But are Romanians willing to pay for private health insurance? One example of a 
private system successfully taken up by the Romanian people is in private pensions. In 
2006, the Government enforced private pensions upon everyone under 35. It asked all its 
younger  citizens  to  choose  a  private  provider  of  pensions  or  they  would  risk  being 
allocated one randomly. This worked, but only because the state compelled the behavioural 
change upon the people.  
At present Romanians pay twice for medical services. Once through the ‘official’ 
public insurance payments as employees and again in informal payments to medics and 
hospital  staff,  especially  for  operations.  This  black  market  in  medical  care  thrives  in 
Romania. There is a chance that Romanians can gradually change their mentality and shift 
their priorities from paying such ‘additional payments’ for medical services to paying a 
prompt and fair amount up-front to insurance companies which will cover the risk.  
Also there is a slight paradox in the industry since during this financial turbulence, 
the insurance business seems to be doing better because people’s awareness of risk is 
higher. They are starting to secure their livelihood and avoid scenarios when they may 
suddenly need a lot of money. Because in Romania there are not enough providers of 
medical  services,  now  is  the  best  moment  to  launch  a  product  that  offers  people  the   6
possibility to be treated abroad, where they can benefit from high quality and services 
unavailable in Romania.  
Part of Romania’s reluctance to invest in private health insurance is also due to a 
lack of information on the subject. Health insurance has not been aggressively marketed to 
Romanians to the same extent as non-life products such as car and home insurance. Health 
insurance is not a luxury, but a commodity which does not enhance one’s social status, 
such as a bigger plasma TV, and when all Romanians understand this, we will deal with a 
different market.  
Now private health insurance packages are the only insurance product that benefit 
from fiscal deductibility from the state. If employers choose to give their employees a 
private  health  insurance  package  as  a  salary  bonus,  the  business  receives  an  annual 
deduction of 250 Euro per employee from taxes on their profit.  
But providers of private health insurance believe there should be more incentives 
for individuals. Now very few choose to voluntarily invest in such products. However 
there is an appetite for private medical care. More than 40 per cent of the population used a 
private medical clinic between June 2008 and June 2009 and spent between 58 and 198 
Euro  on  different  medical  services,  such  as  medical  examinations  and,  especially,  for 
dental services.  
Growth in the private health insurance market depends on the willingness of the 
corporate  sector  to  buy  these  products.  In  this  crisis  period  when  many  companies, 
although restructuring, want to retain their employees, they will want to offer these kind of 
benefits as an incentive.  
Private health insurance can only expand if private medical providers invest and 
vice versa. What is needed is a Government ‘road-map’ on how healthcare will reform 
over five to ten years, agreed between all political parties, so investors can factor in the 
future. In general companies are not positive about growth in health insurance until there is 
a change in policy. 
All in all under the current economic conditions and in the absence of a complete 
health reform, the health insurance market will most likely not register growth during the 
2010-2011 period 
4. CONCLUSIONS 
Mechanisms  in  which  funds  are  generated  and  allocated  in  European  health 
systems  are  very  complex  and  vary  from  country  to  country.  Governments  in  all  EU 
countries are involved in financing health care; most Member States use a combination of 
social contributions and direct government financing of health.  
As  for  private insurance, they  are  a  supplement  rather than asubstitute  for  the 
primary health care system. Health systems are resource intensive, in the last 30 years 
recorded a continuous increase in the level of resources required, increase due mainly to: 
aging,  drug  discovery,  more  efficient  and  more  advanced  technologies,  but  also  more 
costly, increasing number of people receiving healthcare.  
Theoretically, financial support can be improved through a series of measures: 
limiting access to services, reduced service quality or increase the share of private funding 
(which, in turn, has consequences related to limiting access to services). But none of them 
is not desirable from a social perspective. From the perspective of social protection, the 
best way to improve financial support is to increase health system efficiency: efficiency 
concern herelowering costs while maintaining the same levels of quantity and quality, 
achieved by preventing overconsumption (which may be related to over-supply) of health  
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services and the allocation of sufficient resources for programs of prevention and health 
maintenance in order to reduce potential future expenses.  
European Union does not require a role model in terms of funding health services 
or insurance system, leaving each Member State free to decide their own system. Without 
a successful and verified model, each country is forced to create their model without any 
major delays, threatening to cover mistakes made by other methods.  
Aging population, high costs of new medical technology and increasing demands 
of growing population, in turn, demand for produce escalating health care costs over the 
ability of citizens to pay for them in particular through collective means that tax or social 
insurance. In these circumstances, European governments will not provide sufficient levels 
of care and will require additional methods of financing health services.  
At  present,  Romanian  reforms  of  health  care  are  being  implemented.They  are 
intended  to  follow  some  principles  as  accessibility,  universality,  solidarity  in  funding 
health services, incentives for effectiveness and efficiency as well as providing service 
delivery linked to health care needs. But, little is known about what the people think about 
the  reality  covered  by  these  principles.  One  of  the  major  issues  that  should  concern 
policymakers and service providers is the effect of reform on weaker population groups 
such as the poor, chronically ill and elderly. Having an impact on people’s health status 
and with consequences readily visible to the affected publics the outcome of reforms of the 
Romanian health care system may be largely determined by the society’s reaction. 
In the literature, implementation is seen as the most crucial aspect of the policy 
process. It is also known that the outcomes of implementation efforts are highly variable 
(ranging from successful to unsuccessful). The range of outcomes results from the fact that 
implementation is an interactive and ongoing process of decision making by policy elites 
and managers in response to actual or anticipated reactions to reformist initiatives. Usually 
when reforms are implemented, there are some categories of people who are better off and 
some who are worse off than before. But involvement of the population in health care 
reforms may mean that changes are more easily accepted, therefore, there is a better chance 
that reforms are successfully implemented. 
When co-payments will become common, it is essential that patients and doctors 
are willing to cooperate with it. If not, the utilization pattern may be changed and/or other 
ways of  rescription/referral will be developed. 
The Romanian health system reform is urgently needed in order to improve the 
health care financing system. Besides the public health insurance system that provides 
financing  for  a  package  of  basic  health  services,  while  respecting  the  principles  of 
solidarity and obligation of every citizen participation, a vital need for alternative options 
is needed through voluntary insurance, providing additional benefits in return of related 
premiums. This system is expected to influence current management practices of funds in 
hospitals and health insurance funds with the principles and values of the private system, 
contributing to good use the amounts collected. 
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